PHARMACEUTICAL COMPOSITION

To provide a pharmaceutical composition containing as an active ingredient a novel imidazole compound or pharmacologically acceptable salt thereof having melanocortin receptor agonist activity.SOLUTION: A pharmaceutical composition contains an imidazole compound represented by general formula [I] or...

Full description

Saved in:
Bibliographic Details
Main Authors TANIMOTO KOICHI, YAMAMOTO KOO, NAKANE SATORU, SATO ATSUSHI, IMASHIRO RITSUO, TOSHIKAWA CHIHIRO, TSUJIJIMA SHUICHI
Format Patent
LanguageEnglish
Japanese
Published 20.12.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To provide a pharmaceutical composition containing as an active ingredient a novel imidazole compound or pharmacologically acceptable salt thereof having melanocortin receptor agonist activity.SOLUTION: A pharmaceutical composition contains an imidazole compound represented by general formula [I] or a pharmacologically acceptable salt thereof as an active ingredient. [In the formula, ring A represents an optionally substituted aryl group or the like; Rrepresents a hydrogen atom, an optionally substituted alkyl group, or the like; Rrepresents a hydrogen atom, a halogen atom, or the like; and Rrepresents an optionally substituted alkyl group.]SELECTED DRAWING: None 【課題】 メラノコルチン受容体作動活性を有する新規イミダゾール化合物又はその薬理的に許容し得る塩を有効成分として含んでなる医薬組成物の提供。【解決手段】 一般式〔I〕〔式中、環Aは置換されていてもよいアリール基等を表し;R1は水素原子、置換されていてもよいアルキル基等を表し;R2は水素原子、ハロゲン原子等を表し;R3は置換されていてもよいアルキル基を表す〕で示されるイミダゾール化合物、又はその薬理的に許容し得る塩を有効成分として含んでなる医薬組成物。【選択図】 なし
Bibliography:Application Number: JP20180100327